The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Cardiovascular Complications of Cancer Therapy
Open accessAbstract
In this second part of a 2-part review, we will review cancer or cancer-therapy associated systemic and pulmonary hypertension, QT-prolongation, arrhythmias, pericardial disease, and radiation-induced cardiotoxicity. This review is based on MEDLINE literature search, published clinical guidelines, and best practices in major cancer centers. Newly developed targeted therapy can exert off-target effects causing hypertension, thromboembolism, QT-prolongation and atrial fibrillation. Radiation therapy often accelerates atherosclerosis. Furthermore, radiation can damage the heart valves, the conduction system, and pericardium that may take years to manifest clinically. Management of pericardial disease in cancer patients also posed clinical challenges. This review highlights the unique opportunity of caring for cancer patients with heart problems caused by cancer or cancer therapy. It is an invitation to action for cardiologists to become familiar with this emerging subspecialty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,795
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Byrd, J. C., Brown, J. R., O'Brien, S., Barrientos, J. C., Kay, N. E., Reddy, N. M., Coutre, S., Tam, C. S., Mulligan, S. P., Jaeger, U., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400376 · Cited by 1,639
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,634
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Wells, S. A., Robinson, B. G., Gagel, R. F., Dralle, H., Fagin, J. A., Santoro, M., Baudin, E., Elisei, R., Jarzab, B., Vasselli, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5040 · Cited by 1,559
International Conference on Harmonisation
Guy, R. C. (2014) · Encyclopedia of Toxicology · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,478
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Stewart, A. K., Rajkumar, S. V., Dimopoulos, M. A., Masszi, T., Špička, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D. S., Mihaylov, G. G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411321 · Cited by 1,332 · cited 1×
“for Relapsed Multiple Myeloma Patients) and ASPIRE (Carfizomib, Lenalidomide, and Dexamethasone vs Lenalidomide and Dexamethasone in Subjects with Relapsed Multiple Myeloma) studies, the incidence of HTN in patients receiving carfilzomib was 17% and 11%, respectively (20,21).”
BackgroundMiller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Self-citationSunitinib in Patients With Metastatic Renal Cell Carcinoma
Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., Redman, B. G., Margolin, K. A., Merchan, J. R., Wilding, G., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2516 · Cited by 1,230
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
Hooper, C., Laurence, I., Harvey, J., Morley, A., Darby, M., Edey, A., & Maskell, N. (2014) · Respiration · doi:10.1159/000347003 · Cited by 1,184
Duvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025999 · Cited by 1,141
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
Olsen, E. A., Kim, Y. H., Kuzel, T. M., Pacheco, T. R., Foss, F. M., Parker, S., Frankel, S. R., Chen, C., Ricker, J. L., Arduino, J. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2434 · Cited by 1,055
Darby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Ratain, M. J., Eisen, T., Stadler, W. M., Flaherty, K. T., Kaye, S. B., Rosner, G. L., Gore, M., Desai, A. A., Patnaik, A., Xiong, H. Q., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6723 · Cited by 1,032
Mechanisms of adverse effects of anti-VEGF therapy for cancer
Kamba, T., & McDonald, D. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603813 · Cited by 990
Drug induced QT prolongation and torsades de pointes
Yap, Y. G., & Camm, A. J. (2003) · Heart · doi:10.1136/heart.89.11.1363 · Cited by 958
Cortes, J. E., Saglio, G., Kantarjian, H. M., Baccarani, M., Mayer, J., Boqué, C., Shah, N. P., Chuah, C., Casanova, L., Bradley-Garelik, B., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.8899 · Cited by 947
Scappaticci, F. A., Skillings, J. R., Holden, S. N., Gerber, H.-P., Miller, K., Kabbinavar, F., Bergsland, E., Ngai, J., Holmgren, E., Wang, J., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm086 · Cited by 938
Curigliano, G., Cardinale, D., Suter, T., Plataniotis, G., de Azambuja, E., Sandri, M. T., Criscitiello, C., Goldhirsch, A., Cipolla, C., & Roila, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds293 · Cited by 865
Cardiovascular Complications of Cancer Therapy: Diagnosis, Pathogenesis, and Management
Yeh, E. T. H., Tong, A. T., Lenihan, D. J., Yusuf, S. W., Swafford, J., Champion, C., Durand, J.-B., Gibbs, H., Zafarmand, A. A., & Ewer, M. S. (2004) · Circulation · doi:10.1161/01.cir.0000133187.74800.b9 · Cited by 843
Self-citationPrevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian, H., Calleja, E., Stone, R. M., Kalaycio, M., Scheinberg, D. A., Steinherz, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3852 · Cited by 826
Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W. (2010) · Circulation · doi:10.1161/circulationaha.109.192704 · Cited by 821
Factors Affecting Late Mortality From Heart Disease After Treatment of Hodgkin's Disease
Hancock, S. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160067031 · Cited by 773
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Armstrong, G. T., Oeffinger, K. C., Chen, Y., Kawashima, T., Yasui, Y., Leisenring, W., Stovall, M., Chow, E. J., Sklar, C. A., Mulrooney, D. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3205 · Cited by 734
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 659
Risk of Arterial Thromboembolism in Patients With Cancer
Navi, B. B., Reiner, A. S., Kamel, H., Iadecola, C., Okin, P. M., Elkind, M. S. V., Panageas, K. S., & DeAngelis, L. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.047 · Cited by 654
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
Rajkumar, S. V., Hayman, S. R., Lacy, M. Q., Dispenzieri, A., Geyer, S. M., Kabat, B., Zeldenrust, S. R., Kumar, S., Greipp, P. R., Fonseca, R., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2817 · Cited by 648
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Moslehi, J. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1100265 · Cited by 635
Radiation-Related Heart Disease: Current Knowledge and Future Prospects
Darby, S. C., Cutter, D. J., Boerma, M., Constine, L. S., Fajardo, L. F., Kodama, K., Mabuchi, K., Marks, L. B., Mettler, F. A., Pierce, L. J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.064 · Cited by 618
Self-citationBurstein, H. J., Elias, A. D., Rugo, H. S., Cobleigh, M. A., Wolff, A. C., Eisenberg, P. D., Lehman, M., Adams, B. J., Bello, C. L., DePrimo, S. E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5375 · Cited by 489
Haverkamp*, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00119-x · Cited by 486
Cancer drugs and the heart: importance and management
Suter, T. M., & Ewer, M. S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs181 · Cited by 472
Spencer, F. A., Emery, C., Lessard, D., Anderson, F., Emani, S., Aragam, J., Becker, R. C., & Goldberg, R. J. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00458.x · Cited by 445
Risk factors for chronic thromboembolic pulmonary hypertension
Bonderman, D., Wilkens, H., Wakounig, S., Schäfers, H.-J., Jansa, P., Lindner, J., Simkova, I., Martischnig, A. M., Dudczak, J., Sadushi, R., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00087608 · Cited by 441
Hennekens, C. H., Dyken, M. L., & Fuster, V. (1997) · Circulation · doi:10.1161/01.cir.96.8.2751 · Cited by 435
Choueiri, T. K., Schutz, F. A. B., Je, Y., Rosenberg, J. E., & Bellmunt, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2757 · Cited by 434
Haverkamp, W. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2249 · Cited by 414
Maitland, M. L., Bakris, G. L., Black, H. R., Chen, H. X., Durand, J.-B., Elliott, W. J., Ivy, S. P., Leier, C. V., Lindenfeld, J., Liu, G., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq091 · Cited by 410
Cardiac Complications of Thoracic Irradiation
Jaworski, C., Mariani, J. A., Wheeler, G., & Kaye, D. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.090 · Cited by 393
Asymptomatic cardiac disease following mediastinal irradiation
Heidenreich, P. A., Hancock, S. L., Lee, B. K., Mariscal, C. S., & Schnittger, I. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00759-9 · Cited by 393
Farmakis, D., Parissis, J., & Filippatos, G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.026 · Cited by 387
Prevention of Torsade de Pointes in Hospital Settings
Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.001 · Cited by 367
Writing Committee Members, Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189741 · Cited by 366
Gupta, A., Lawrence, A. T., Krishnan, K., Kavinsky, C. J., & Trohman, R. G. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.040 · Cited by 362
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Dy, G. K., & Adjei, A. A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21184 · Cited by 331
Mechanisms of Hypertension Associated With BAY 43-9006
Veronese, M. L., Mosenkis, A., Flaherty, K. T., Gallagher, M., Stevenson, J. P., Townsend, R. R., & O'Dwyer, P. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0503 · Cited by 324
Palumbo, A., Cavo, M., Bringhen, S., Zamagni, E., Romano, A., Patriarca, F., Rossi, D., Gentilini, F., Crippa, C., Galli, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6844 · Cited by 323
Palumbo, A., Falco, P., Corradini, P., Falcone, A., Di Raimondo, F., Giuliani, N., Crippa, C., Ciccone, G., Omedè, P., Ambrosini, M. T., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3463 · Cited by 319
Predicting drug–hERG channel interactions that cause acquired long QT syndrome
Sanguinetti, M. C., & Mitcheson, J. S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.003 · Cited by 300
Sawyer, D. B., Zuppinger, C., Miller, T. A., Eppenberger, H. M., & Suter, T. M. (2002) · Circulation · doi:10.1161/01.cir.0000013839.41224.1c · Cited by 292
Clinical Cardiac Tolerability of Trastuzumab
Perez, E. A., & Rodeheffer, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.120 · Cited by 280
Ranpura, V., Hapani, S., Chuang, J., & Wu, S. (2010) · Acta Oncologica · doi:10.3109/02841860903524396 · Cited by 276
Direct Oral Anticoagulants in Patients With VTE and Cancer
Vedovati, M. C., Germini, F., Agnelli, G., & Becattini, C. (2015) · Chest · doi:10.1378/chest.14-0402 · Cited by 270
Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease
Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., Tate, D. J., Horning, S. J., Hoppe, R. T., & Hancock, S. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0805 · Cited by 262
Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors
Vasan, R. S., Sullivan, L. M., Wilson, P. W. F., Sempos, C. T., Sundström, J., Kannel, W. B., Levy, D., & D'Agostino, R. B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00005 · Cited by 236
The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis
Leong, D. P., Caron, F., Hillis, C., Duan, A., Healey, J. S., Fraser, G., & Siegal, D. (2016) · Blood · doi:10.1182/blood-2016-05-712828 · Cited by 233
Virani, S. A., Dent, S., Brezden-Masley, C., Clarke, B., Davis, M. K., Jassal, D. S., Johnson, C., Lemieux, J., Paterson, I., Sebag, I. A., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.078 · Cited by 231
Cardiac amyloidosis: Updates in diagnosis and management
Mohty, D., Damy, T., Cosnay, P., Echahidi, N., Casset-Senon, D., Virot, P., & Jaccard, A. (2013) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2013.06.051 · Cited by 229
Management of thalidomide toxicity.
Ghobrial, I. M., & Rajkumar, S. V. (2003) · PubMed · Cited by 227
Hurwitz, H. I., Saltz, L. B., Van Cutsem, E., Cassidy, J., Wiedemann, J., Sirzén, F., Lyman, G. H., & Rohr, U.-P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.3220 · Cited by 226
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
Streiff, M. B., Holmstrom, B., Ashrani, A., Bockenstedt, P. L., Chesney, C., Eby, C., Fanikos, J., Fenninger, R. B., Fogerty, A. E., Gao, S., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0133 · Cited by 218
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis
Berger, J. S., Brown, D. L., & Becker, R. C. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.002 · Cited by 203
Hu, Y.-F., Liu, C.-J., Chang, P. M.-H., Tsao, H.-M., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Tuan, T.-C., Li, C.-H., Chao, T.-F., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.08.036 · Cited by 198
Angiogenic growth factors and hypertension
Sane, D. C., Anton, L., & Brosnihan, K. B. (2004) · Angiogenesis · doi:10.1007/s10456-004-2699-3 · Cited by 195
Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma
Furuse, J., Ishii, H., Nakachi, K., Suzuki, E., Shimizu, S., & Nakajima, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00648.x · Cited by 194
CARRIER, M., LE GAL, G., TAY, J., WU, C., & LEE, A. Y. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04215.x · Cited by 193
Steeghs, N., Gelderblom, H., Roodt, J. O. '., Christensen, O., Rajagopalan, P., Hovens, M., Putter, H., Rabelink, T. J., & de Koning, E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5050 · Cited by 190
Hijazi, Z., Hohnloser, S. H., Andersson, U., Alexander, J. H., Hanna, M., Keltai, M., Parkhomenko, A., López-Sendón, J. L., Lopes, R. D., Siegbahn, A., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1170 · Cited by 173
Carrier, M., Cameron, C., Delluc, A., Castellucci, L., Khorana, A. A., & Lee, A. Y. Y. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.09.039 · Cited by 172
The Fifth World Symposium on Pulmonary Hypertension
Galiè, N., & Simonneau, G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.030 · Cited by 152
Ischemic Heart Disease after Breast Cancer Radiotherapy
Darby, S. C., Ewertz, M., & Hall, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1304601 · Cited by 148
Baz, R., Walker, E., Karam, M. A., Choueiri, T. K., Jawde, R. M. A., Bruening, K., Reed, J., Faiman, B. M., Ellis, Y., Brand, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl313 · Cited by 147
Ghatalia, P., Je, Y., Kaymakcalan, M. D., Sonpavde, G., & Choueiri, T. K. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.564 · Cited by 132
Clinical features of pulmonary arterial hypertension in patients receiving dasatinib
Shah, N. P., Wallis, N., Farber, H. W., Mauro, M. J., Wolf, R. A., Mattei, D. G., Guha, M., Réa, D., & Peacock, A. J. (2015) · American Journal of Hematology · doi:10.1002/ajh.24174 · Cited by 128
Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors
Lenihan, D. J., & Kowey, P. R. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0466 · Cited by 128
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study
Thompson, P. A., Lévy, V., Tam, C. S. L., Al‐Nawakil, C., Goudot, F., Quinquenel, A., Ysebaert, L., Michallet, A., Dilhuydy, M., Neste, E. V. D., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14324 · Cited by 124
Voortman, J., & Giaccone, G. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-129 · Cited by 123
Symonds, R. P., Gourley, C., Davidson, S. E., Carty, K., McCartney, E., Rai, D., Banerjee, S. N., Jackson, D. P., Lord, R., McCormack, M. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00220-x · Cited by 119
Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer
Boero, I. J., Paravati, A. J., Triplett, D. P., Hwang, L., Matsuno, R. K., Gillespie, E. F., Yashar, C. M., Moiseenko, V., Einck, J. P., Mell, L. K., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.12.018 · Cited by 114
Rasheed, W. K., Flaim, B., & Seymour, J. F. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.026 · Cited by 106
Izzedine, H., Derosa, L., Teuff, G. L., Albiges, L. K., & Escudier, B. J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv147 · Cited by 104
Qi, W., Min, D., Shen, Z., Sun, Y., Lin, F., Tang, L., He, A., & Yao, Y. (2012) · International Journal of Cancer · doi:10.1002/ijc.27979 · Cited by 104
Mantha, S. H., Laube, E., Miao, Y., Sarasohn, D. M. M., Parameswaran, R., Stefanik, S., Brar, G. S., Samedy, P., Wills, J., Harnicar, S. J., et al. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1429-1 · Cited by 104
Groarke, J. D., Tanguturi, V. K., Hainer, J. M., Klein, J., Moslehi, J. J., Ng, A. K., Forman, D. E., Carli, M. F. D., & Nohria, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.035 · Cited by 99
First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation
Guzzetti, S., Costantino, G., Vernocchi, A., Sada, S., & Fundarò, C. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0124-4 · Cited by 95
Chemotherapy agents and hypertension: A focus on angiogenesis blockade
Jain, M. K., & Townsend, R. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0058-7 · Cited by 92
Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case–control study
Erichsen, R., Christiansen, C. F., Mehnert, F., Weiss, N. S., Baron, J. A., & Sørensen, H. T. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0701-9 · Cited by 88
Faruque, L. I., Lin, M., Battistella, M., Wiebe, N., Reiman, T., Hemmelgarn, B. R., Thomas, C. M., & Tonelli, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101145 · Cited by 87
Radiation-Induced Heart Disease
Filopei, J., & Frishman, W. H. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e3182431c23 · Cited by 84
The Diagnosis and Management of Cardiovascular Disease in Cancer Patients
Yusuf, S. W., Razeghi, P., & Yeh, E. T. H. (2008) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2008.01.002 · Cited by 80
Self-citationHak, Ł., Myśliwska, J. M., Wickiewicz, J., Szyndler, K., Siebert, J., & Rogowski, J. A. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0082.2906 · Cited by 79
Dutcher, J. P., Fisher, R. I., Weiss, G. R., Aronson, F. R., Margolin, K. A., Louie, A. C., Mier, J. W., Caliendo, G., Sosman, J. A., Eckardt, J. R., et al. (1997) · PubMed · Cited by 78
Sonpavde, G., Je, Y., Schutz, F. A. B., Galsky, M. D., Paluri, R. K., Rosenberg, J. E., Joaquim Bellmunt, B., & Choueiri, T. K. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.12.006 · Cited by 73
Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance
Palumbo, A., & Palladino, C. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612452291 · Cited by 70
Angiotensin-Converting Enzyme Inhibitors for Bevacizumab-Induced Hypertension
Dinçer, M., & Altundağ, K. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h244 · Cited by 68
Haas, N. B., Manola, J. B., Ky, B., Flaherty, K. T., Uzzo, R. G., Kane, C. J., Jewett, M. A. S., Wood, L. A., Wood, C. G., Atkins, M. B., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0215 · Cited by 66
Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer
Verma, V., Shah, C., & Mehta, M. P. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.02.006 · Cited by 66
Musallam, K. M., Dahdaleh, F. S., Shamseddine, A. I., & Taher, A. T. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.09.008 · Cited by 63
Thalidomide-Induced Sinus Bradycardia
Kaur, A., Yu, S. S., Lee, A. J., & Chiao, T. B. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d003 · Cited by 56
Flaherty, L. E., Hamid, O., Linette, G. P., Schuchter, L. M., Hallmeyer, S., Gonzalez, R. C., Cowey, C. L., Pavlick, A. C., Kudrik, F. J., Curti, B. D., et al. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000024 · Cited by 55
Enriquez, A. A., Biagi, J. J., Redfearn, D., Boles, U., Kamel, D., Ali, F. S., Hopman, W. M., Michael, K. A., Simpson, C. S., Abdollah, H., et al. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.03.001 · Cited by 54
Omalizumab for Chronic Urticaria
Maurer, M., Rosén, K. E., & Hsieh, H.-J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1305687 · Cited by 53
Sorafenib for Metastatic Renal Cancer
Riechelmann, R. P., Chin, S. F., Wang, L. E., Tannock, I. F., Berthold, D., Moore, M. J., & Knox, J. J. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181574084 · Cited by 52
Streitner, F., Kuschyk, J., Veltmann, C., Ratay, D., Schoene, N., Streitner, I., Brueckmann, M., Schumacher, B., Borggrefe, M., & Wolpert, C. (2009) · Cytokine · doi:10.1016/j.cyto.2009.06.003 · Cited by 47
Hypertension induced by chemotherapeutic and immunosuppresive agents: A new challenge
Aad, S. A., Pierce, M. J., BARMAIMON, G., Farhat, F., Benjo, A. M., & Mouhayar, E. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.08.004 · Cited by 46
Management of atrial fibrillation in patients taking targeted cancer therapies
Asnani, A. H., Manning, A., Mansour, M., Ruskin, J. N., Hochberg, E. P., & Ptaszek, L. M. (2017) · Cardio-Oncology · doi:10.1186/s40959-017-0021-y · Cited by 39
QT interval prolongation among patients treated with angiogenesis inhibitors
Éderhy, S., Cohen, A. A., Dufaître, G., Izzedine, H., Massard, C., Meuleman, C., Besse, B., Berthelot, E., Boccara, F., & Soria, J. (2009) · Targeted Oncology · doi:10.1007/s11523-009-0111-3 · Cited by 33
Anders, J. C., Grigsby, P. W., & Singh, A. K. (2006) · Radiation Oncology · doi:10.1186/1748-717x-1-14 · Cited by 31
Ibrutinib-related atrial fibrillation in patients with mantle cell lymphoma
Lee, H. J., Chihara, D., Wang, M. L., Mouhayar, E., & Kim, P. Y. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2016.1169408 · Cited by 27
Radiation-associated valvular heart disease.
Ds, O., Ra, A., Clark, A. N., et al. (2013) · PubMed · Cited by 27
Yeh, E. T. H., & Chang, H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.719 · Cited by 23
Self-citationChemotherapy and QT Prolongation: Overview With Clinical Perspective
Kim, P. Y., & Ewer, M. S. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0303-8 · Cited by 20
Krüse, V., Somers, A., Bortel, L. M. V., Both, A., Belle, S. V., & Rottey, S. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12134 · Cited by 16
An Unusual Cause of Reflex Cardiovascular Syncope: Vagal Paraganglioma
Ökmen, E., Erdinler, I. C., Oğuz, E., et al. (2003) · Annals of Noninvasive Electrocardiology · doi:10.1046/j.1542-474x.2003.08215.x · Cited by 12
What is QT interval prolongation?
Vorchheimer, D. A. (2005) · PubMed · Cited by 12
Post-radiation valvular and coronary artery disease.
Gonzaga, A. T., & Antunes, M. J. (1997) · PubMed · Cited by 11
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Metadata
- Authors
- Chang, H.-M., Okwuosa, T. M., Scarabelli, T., Moudgil, R., & Yeh, E. T. H.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 70
- Issue
- 20
- Pages
- 2552-2565
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2915976688
- Cited by
- 290
- References
- 141
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.